Yury Kiselev

802 total citations
24 papers, 627 citations indexed

About

Yury Kiselev is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Yury Kiselev has authored 24 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Infectious Diseases and 5 papers in Oncology. Recurrent topics in Yury Kiselev's work include COVID-19 Clinical Research Studies (5 papers), MicroRNA in disease regulation (3 papers) and Infectious Encephalopathies and Encephalitis (3 papers). Yury Kiselev is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), MicroRNA in disease regulation (3 papers) and Infectious Encephalopathies and Encephalitis (3 papers). Yury Kiselev collaborates with scholars based in Norway, Russia and Bangladesh. Yury Kiselev's co-authors include Lill‐Tove Busund, Roy M. Bremnes, Elin Richardsen, Sigve Andersen, Samer Al‐Saad, Tom Dønnem, Khalid Al‐Shibli, Sigurd M. Hald, Thomas K. Kilvær and Olfred Hansen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Physics Letters and PLoS ONE.

In The Last Decade

Yury Kiselev

22 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yury Kiselev Norway 12 294 202 184 173 140 24 627
Lisa Leung Canada 9 241 0.8× 267 1.3× 142 0.8× 79 0.5× 57 0.4× 12 506
Oh Kyu Yoon United States 16 352 1.2× 207 1.0× 96 0.5× 167 1.0× 46 0.3× 31 754
Garry Ashton United Kingdom 15 217 0.7× 303 1.5× 162 0.9× 91 0.5× 117 0.8× 22 773
Margaret Sutcliffe Canada 9 167 0.6× 165 0.8× 101 0.5× 103 0.6× 48 0.3× 11 492
Giada Munari Italy 15 199 0.7× 170 0.8× 154 0.8× 95 0.5× 37 0.3× 50 517
Anya M. Litvak United States 12 596 2.0× 233 1.2× 104 0.6× 243 1.4× 83 0.6× 15 900
Yan‐Yi Jiang China 21 259 0.9× 719 3.6× 312 1.7× 230 1.3× 57 0.4× 37 1.0k
Masataka Adachi Japan 15 110 0.4× 270 1.3× 182 1.0× 47 0.3× 59 0.4× 41 790
J. Ferreira Belgium 9 105 0.4× 259 1.3× 81 0.4× 292 1.7× 48 0.3× 15 685
Zhaopei Liu China 14 313 1.1× 197 1.0× 71 0.4× 217 1.3× 259 1.9× 41 682

Countries citing papers authored by Yury Kiselev

Since Specialization
Citations

This map shows the geographic impact of Yury Kiselev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yury Kiselev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yury Kiselev more than expected).

Fields of papers citing papers by Yury Kiselev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yury Kiselev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yury Kiselev. The network helps show where Yury Kiselev may publish in the future.

Co-authorship network of co-authors of Yury Kiselev

This figure shows the co-authorship network connecting the top 25 collaborators of Yury Kiselev. A scholar is included among the top collaborators of Yury Kiselev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yury Kiselev. Yury Kiselev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kiselev, Yury, Margrete Larsen Burns, Kari Modalsli Aaberg, et al.. (2022). Changes in the use of antiseizure medications in children and adolescents in Norway, 2009–2018. Epilepsy Research. 181. 106872–106872. 10 indexed citations
2.
Мирзаев, К. Б., et al.. (2020). “PharmaCOVID” – information center for pharmacotherapy of patients with new coronavirus infection COVID-19. Фарматека. 5_2020. 10–14. 1 indexed citations
3.
Kiselev, Yury, et al.. (2020). What are the indications for combined use of hydroxychloroquine and lopinavir/ritonavir, and how should treatment safety monitoring be performed?. SHILAP Revista de lepidopterología. 47–49. 1 indexed citations
4.
Kiselev, Yury, et al.. (2020). Current and future use of colchicine in patients with COVID-19. SHILAP Revista de lepidopterología. 71–74.
5.
Kiselev, Yury, Marte Handal, Vidar Hjellvik, et al.. (2020). Nationwide Study of Neuropsychiatric Comorbidity and Medicines Use in Children With Autism Spectrum Disorder in Norway. Frontiers in Psychiatry. 11. 596032–596032. 8 indexed citations
6.
Kiselev, Yury, Ksenia Zagorodnikova, К. Б. Мирзаев, et al.. (2020). Current and future use of umifenovir in patients with COVID-19. SHILAP Revista de lepidopterología. 75–80. 1 indexed citations
7.
Kiselev, Yury, et al.. (2020). Monitoring of safety using favipiravir: risk management of adverse drug reactions in clinical practice. SHILAP Revista de lepidopterología. 115–119. 2 indexed citations
8.
Мирзаев, К. Б., et al.. (2020). Supporting frontline clinicians in the time of the pandemic: Rapid response pharmacology team. British Journal of Clinical Pharmacology. 87(3). 725–729. 1 indexed citations
9.
Мирзаев, К. Б., Yury Kiselev, & Д. А. Сычев. (2020). Methylprednisolone in acute respiratory distress-syndrome in COVID-19: rationales for use, optimal dosage regimens, combined use with tocilizumab. SHILAP Revista de lepidopterología. 23–27.
10.
Kiselev, Yury, Sigve Andersen, Karina Standahl Olsen, et al.. (2018). Transcription factor PAX6 as a novel prognostic factor and putative tumour suppressor in non-small cell lung cancer. Scientific Reports. 8(1). 5059–5059. 13 indexed citations
11.
Kiselev, Yury, et al.. (2017). Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer. PLoS ONE. 12(10). e0186658–e0186658. 30 indexed citations
12.
Dønnem, Tom, Sigurd M. Hald, Erna‐Elise Paulsen, et al.. (2015). Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer. Clinical Cancer Research. 21(11). 2635–2643. 252 indexed citations
13.
Andersen, Sigve, Samer Al‐Saad, Tom Dønnem, et al.. (2015). High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure. PLoS ONE. 10(2). e0116691–e0116691. 42 indexed citations
14.
15.
Hald, Sigurd M., Yury Kiselev, Samer Al‐Saad, et al.. (2015). Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. BMC Cancer. 15(1). 441–441. 30 indexed citations
16.
Andersen, Sigve, Samer Al‐Saad, Yury Kiselev, et al.. (2014). Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival. PLoS ONE. 9(9). e105038–e105038. 63 indexed citations
17.
18.
Ness, Nora, Sigve Andersen, Tom Dønnem, et al.. (2014). Stromal Expression of MiR-21 Predicts Biochemical Failure in Prostate Cancer Patients with Gleason Score 6. PLoS ONE. 9(11). e113039–e113039. 35 indexed citations
19.
20.
Kiselev, Yury & L. E. Golub. (2011). Optical and photogalvanic properties of graphene superlattices formed by periodic strain. Physical Review B. 84(23). 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Leung Breakdown of academic impact, for papers by Oh Kyu Yoon Breakdown of academic impact, for papers by Garry Ashton Breakdown of academic impact, for papers by Margaret Sutcliffe Breakdown of academic impact, for papers by Giada Munari Breakdown of academic impact, for papers by Anya M. Litvak Breakdown of academic impact, for papers by Yan‐Yi Jiang Breakdown of academic impact, for papers by Masataka Adachi Breakdown of academic impact, for papers by J. Ferreira Breakdown of academic impact, for papers by Zhaopei Liu
Rankless by CCL
2026